6.64
-0.08(-1.19%)
Currency In USD
Previous Close | 6.72 |
Open | 6.71 |
Day High | 6.77 |
Day Low | 6.61 |
52-Week High | 10.79 |
52-Week Low | 4.54 |
Volume | 86,957 |
Average Volume | 323,574 |
Market Cap | 419.47M |
PE | -8.41 |
EPS | -0.79 |
Moving Average 50 Days | 6.66 |
Moving Average 200 Days | 7.32 |
Change | -0.08 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $260.09 as of September 30, 2025 at a share price of $6.64. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $300.86 as of September 30, 2025 at a share price of $6.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
GlobeNewswire Inc.
Sep 10, 2025 11:05 AM GMT
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defo
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
GlobeNewswire Inc.
Aug 07, 2025 8:01 PM GMT
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
GlobeNewswire Inc.
Aug 05, 2025 8:05 PM GMT
PONTE VEDRA, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor